Viridian Therapeutics
VRDN
#3908
Rank
โ‚น274.14 B
Marketcap
โ‚น2,872
Share price
-0.44%
Change (1 day)
73.71%
Change (1 year)

Viridian Therapeutics (VRDN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น6.68 Billion

According to Viridian Therapeutics's latest financial reports the company's total liabilities are โ‚น6.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viridian Therapeutics - Total liabilities on balance sheet (from 2013 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น6.07 B50.66%
2023-12-31โ‚น4.02 B21.65%
2022-12-31โ‚น3.31 B178.25%
2021-12-31โ‚น1.19 B45.09%
2020-12-31โ‚น0.82 B-20.7%
2019-12-31โ‚น1.03 B-0.05%
2018-12-31โ‚น1.03 B16.03%
2017-12-31โ‚น0.89 B186.31%
2016-12-31โ‚น0.31 B88.14%
2015-12-31โ‚น0.16 B24.55%
2014-12-31โ‚น0.13 B-92.19%
2013-12-31โ‚น1.70 B28.38%
2012-12-31โ‚น1.32 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น2.18 B-67.27%๐Ÿ‡บ๐Ÿ‡ธ USA